These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules. Harilal S; Jose J; Parambi DGT; Kumar R; Unnikrishnan MK; Uddin MS; Mathew GE; Pratap R; Marathakam A; Mathew B Brain Res Bull; 2020 Jul; 160():121-140. PubMed ID: 32315731 [TBL] [Abstract][Full Text] [Related]
6. Current Strategies for Brain Drug Delivery. Dong X Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336 [TBL] [Abstract][Full Text] [Related]
7. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. Lamptey RNL; Chaulagain B; Trivedi R; Gothwal A; Layek B; Singh J Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163773 [TBL] [Abstract][Full Text] [Related]
8. The blood-brain barrier in health and chronic neurodegenerative disorders. Zlokovic BV Neuron; 2008 Jan; 57(2):178-201. PubMed ID: 18215617 [TBL] [Abstract][Full Text] [Related]
9. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. Teixeira MI; Lopes CM; Amaral MH; Costa PC Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574 [TBL] [Abstract][Full Text] [Related]
10. "Focused Ultrasound-mediated Drug Delivery in Humans - a Path Towards Translation in Neurodegenerative Diseases". Wasielewska JM; White AR Pharm Res; 2022 Mar; 39(3):427-439. PubMed ID: 35257286 [TBL] [Abstract][Full Text] [Related]
11. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. Lossinsky AS; Shivers RR Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715 [TBL] [Abstract][Full Text] [Related]
12. The blood-brain barrier: structure, function and therapeutic approaches to cross it. Tajes M; Ramos-Fernández E; Weng-Jiang X; Bosch-Morató M; Guivernau B; Eraso-Pichot A; Salvador B; Fernàndez-Busquets X; Roquer J; Muñoz FJ Mol Membr Biol; 2014 Aug; 31(5):152-67. PubMed ID: 25046533 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. Saraiva C; Praça C; Ferreira R; Santos T; Ferreira L; Bernardino L J Control Release; 2016 Aug; 235():34-47. PubMed ID: 27208862 [TBL] [Abstract][Full Text] [Related]
14. In Vitro Modeling of the Blood-Brain Barrier for the Study of Physiological Conditions and Alzheimer's Disease. Schreiner TG; Creangă-Murariu I; Tamba BI; Lucanu N; Popescu BO Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009030 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System. Carpanini SM; Torvell M; Morgan BP Front Immunol; 2019; 10():362. PubMed ID: 30886620 [TBL] [Abstract][Full Text] [Related]
16. Transport Across the Blood-Brain Barrier. Fu BM Adv Exp Med Biol; 2018; 1097():235-259. PubMed ID: 30315549 [TBL] [Abstract][Full Text] [Related]
17. Nanostructures for drug delivery to the brain. Martin-Banderas L; Holgado MA; Venero JL; Alvarez-Fuentes J; Fernández-Arévalo M Curr Med Chem; 2011; 18(34):5303-21. PubMed ID: 22087827 [TBL] [Abstract][Full Text] [Related]
18. Basal lamina changes in neurodegenerative disorders. Nguyen B; Bix G; Yao Y Mol Neurodegener; 2021 Dec; 16(1):81. PubMed ID: 34876200 [TBL] [Abstract][Full Text] [Related]
19. The Role of Neurovascular System in Neurodegenerative Diseases. Ahmad A; Patel V; Xiao J; Khan MM Mol Neurobiol; 2020 Nov; 57(11):4373-4393. PubMed ID: 32725516 [TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders. Uprety A; Kang Y; Kim SY Arch Pharm Res; 2021 May; 44(5):487-498. PubMed ID: 34028650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]